IRIS
CASTELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.892
AS - Asia 2.080
SA - Sud America 1.524
EU - Europa 546
AF - Africa 92
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.757
BR - Brasile 1.348
SG - Singapore 929
CN - Cina 351
VN - Vietnam 271
HK - Hong Kong 209
IT - Italia 121
FR - Francia 95
AR - Argentina 77
DE - Germania 68
MX - Messico 61
FI - Finlandia 49
GB - Regno Unito 45
IN - India 42
TR - Turchia 39
CA - Canada 30
IQ - Iraq 30
RU - Federazione Russa 29
ZA - Sudafrica 29
JP - Giappone 27
BD - Bangladesh 26
EC - Ecuador 26
CO - Colombia 24
ID - Indonesia 21
UA - Ucraina 21
UZ - Uzbekistan 21
MA - Marocco 20
SE - Svezia 20
PL - Polonia 18
ES - Italia 15
VE - Venezuela 15
AT - Austria 14
JO - Giordania 13
PY - Paraguay 12
AZ - Azerbaigian 11
PK - Pakistan 11
KE - Kenya 10
CL - Cile 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
NL - Olanda 7
PH - Filippine 7
RS - Serbia 7
TN - Tunisia 7
IL - Israele 6
JM - Giamaica 6
KR - Corea 6
KZ - Kazakistan 6
SA - Arabia Saudita 6
UY - Uruguay 6
CR - Costa Rica 5
EG - Egitto 5
LB - Libano 5
AL - Albania 4
AU - Australia 4
GE - Georgia 4
LT - Lituania 4
PE - Perù 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
IE - Irlanda 3
KG - Kirghizistan 3
PA - Panama 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
BN - Brunei Darussalam 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
Totale 7.128
Salva come PNG Salva come JPEG
Città #
Dallas 1.354
Singapore 486
Chandler 229
San Jose 215
Hong Kong 204
Ashburn 162
Princeton 138
Beijing 101
Ho Chi Minh City 98
São Paulo 87
Lauterbourg 80
New York 77
Shanghai 46
Rio de Janeiro 45
Hanoi 42
Los Angeles 37
Belo Horizonte 34
Helsinki 33
Brasília 30
Tokyo 27
Santa Clara 26
Curitiba 22
Milan 21
Da Nang 20
Orem 20
Munich 18
Warsaw 17
Council Bluffs 16
Tashkent 16
Baghdad 15
Goiânia 15
Campinas 14
Johannesburg 14
Mexico City 14
Porto Alegre 14
Ribeirão Preto 14
Stockholm 14
Chennai 13
Denver 13
Frankfurt am Main 13
Guarulhos 13
Nuremberg 13
Sassari 13
Amman 12
Atlanta 12
Falkenstein 12
Fortaleza 12
Haiphong 12
Santo André 12
São José dos Campos 12
Columbus 11
Duque de Caxias 11
Montreal 11
Poplar 11
The Dalles 11
Baku 10
Brooklyn 10
Nairobi 10
Sorocaba 10
Düsseldorf 9
Franca 9
Quito 9
Tianjin 9
Turku 9
Bogotá 8
Campo Grande 8
Cape Town 8
Joinville 8
London 8
Petrópolis 8
Phoenix 8
Recife 8
Vienna 8
Ankara 7
Asunción 7
Betim 7
Brno 7
Casablanca 7
Dhaka 7
Guayaquil 7
Istanbul 7
Juiz de Fora 7
Maceió 7
Manaus 7
Medellín 7
Olbia 7
Querétaro 7
Shenzhen 7
São Gonçalo 7
Amsterdam 6
Catanduva 6
Caxias do Sul 6
Conselheiro Lafaiete 6
Contagem 6
Cotia 6
Cuiabá 6
Houston 6
Hải Dương 6
Itapevi 6
Lahore 6
Totale 4.367
Salva come PNG Salva come JPEG
Nome #
Impact of recombinant erythropoietin on anemia, physical function, and cognitive assessment in hospitalized older adults 365
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 219
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 174
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 162
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 142
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 140
Aging of the Arterial System 136
Cancer and thromboembolism: from biology to clinics 125
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 123
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 117
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 114
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 111
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 107
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 106
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 104
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 102
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 101
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 99
Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction 98
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 98
Choosing treatment options for patients with relapsed/refractory multiple myeloma 97
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 96
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 94
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 94
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 92
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 88
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 87
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 86
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 86
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 84
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 83
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 82
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 82
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 80
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 80
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 79
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 77
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 77
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 77
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 76
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 76
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 75
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 73
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 73
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 73
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 72
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 71
The heparins and cancer: review of clinical trials and biological properties 71
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 70
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 70
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 70
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 70
Interaction of C1 inhibitor with thrombin on the endothelial surface 69
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 68
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update 66
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 66
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 66
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 65
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 65
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 65
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 63
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 62
Rheumatoid factors : clinical applications 61
Thrombosis and hemostatic Abnormalities in haematological malignancies 60
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 60
Ibrutinib related bleeding complications in elderly patients with B cell malignancies 59
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 59
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 59
Thromboembolic complications in malignant haematological disorders 59
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 58
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 57
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 57
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 54
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 53
Intrathoracic masses due to extramedullary hematopoiesis 51
New antithrobotic agents 50
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 49
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study 48
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 48
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 47
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 47
Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures 45
null 45
Lymphoproliferative disease and acquired C1 inhibitor deficiency 42
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 40
Risk-tailored treatment of splenic marginal zone lymphoma 40
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 39
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 6
Totale 7.252
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 0 0 0 0 83 0 3 4 21 89
2022/2023515 69 0 2 85 50 77 0 85 96 8 25 18
2023/2024213 26 22 5 3 8 57 2 10 0 6 17 57
2024/20252.370 10 13 84 24 104 81 169 631 800 294 69 91
2025/20263.954 153 950 831 797 321 175 400 112 121 94 0 0
Totale 7.252